NCT06734533 2024-12-16
Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive(HR+) Metastatic Breast Cancer(MBC) .
Hunan Cancer Hospital
Recruiting
Hunan Cancer Hospital
MedSIR
The Affiliated Hospital of Qingdao University
Hunan Cancer Hospital
Fudan University
Blokhin's Russian Cancer Research Center
Istituti Clinici Scientifici Maugeri SpA
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Xijing Hospital
Hellenic Oncology Research Group